Circulating Tumor Cell Number as a Response Measure of Prolonged Survival for Metastatic Castration-Resistant Prostate Cancer: Is Real Circulating Tumor Cell Number Superior to Prostate-Specific Antigen? Reply

著录项

• 来源
  《Journal of Clinical Oncology》 |2018年第22期|共3页
• 作者

  Heller Glenn; McCormack Robert; Kheoh Thian; Molina Arturo; Smith Matthew R.; Dreicer Robert; Saad Fred; de Wit Ronald; Aftab Dana T.; Hirmand Mohammed; Limon-Carrera Ana; Fizazi Karim; Fleisher Martin; de Bono Johann S.; Scher Howard I.;

  展开▼
• 作者单位

  Mem Sloan Kettering Canc Ctr 1275 York Ave New York NY 10021 USA;

  Janssen Res &

  Dev Raritan NJ USA;

  Janssen Res &

  Dev Raritan NJ USA;

  Janssen Res &

  Dev Los Angeles CA USA;

  Massachusetts Gen Hosp Boston MA 02114 USA;

  Univ Virginia Sch Med Charlottesville VA 22908 USA;

  Univ Montreal Montreal PQ Canada;

  Erasmus MC Rotterdam Netherlands;

  Exelixis San Francisco CA USA;

  Medivation San Francisco CA USA;

  Takeda Oncol Cambridge MA USA;

  Inst Gustave Roussy Villejuif France;

  Mem Sloan Kettering Canc Ctr 1275 York Ave New York NY 10021 USA;

  Inst Canc Res Sutton Surrey England;

  Mem Sloan Kettering Canc Ctr 1275 York Ave New York NY 10021 USA;

  展开▼
• 收录信息
• 原文格式 PDF
• 正文语种 eng
• 中图分类 肿瘤学;
• 关键词